Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
-17.22%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$29.7B
AUM Growth
-$3.54B
(-11%)
Cap. Flow
+$638M
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
8.38%
Holding
3,122
New
604
Increased
748
Reduced
961
Closed
731
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$249M |
| 2 |
Oracle
ORCL
|
+$236M |
| 3 |
Microsoft
MSFT
|
+$233M |
| 4 |
Bank of America
BAC
|
+$215M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$205M |
Top Sells
| 1 |
Merck
MRK
|
+$267M |
| 2 |
Tesla
TSLA
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$212M |
| 5 |
Walmart
WMT
|
+$211M |
Sector Composition
| 1 | Technology | 19.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 11.22% |
| 4 | Industrials | 10.59% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNR
1526
Burning Rock Biotech
BNR
$89.4M
| $873K | ﹤0.01% |
+29,988
| New | +$873K |
|
1527
ARKO Corp
ARKO
$564M
| $872K | ﹤0.01% |
106,881
-131,500
| -55% | -$1.07M |
|
1528
Crinetics Pharmaceuticals
CRNX
$3.2B
| $872K | ﹤0.01% |
46,745
-74,032
| -61% | -$1.38M |
|
|
CCEC
1529
Capital Clean Energy Carriers Corp. Common Share
CCEC
$1.24B
| $871K | ﹤0.01% |
57,475
-99,912
| -63% | -$1.51M |
|
|
VERV
1530
DELISTED
Verve Therapeutics
VERV
| $868K | ﹤0.01% |
56,781
+29,187
| +106% | +$446K |
|
1531
Kratos Defense & Security Solutions
KTOS
$11.7B
| $864K | ﹤0.01% |
+62,228
| New | +$864K |
|
1532
Forward Air
FWRD
$902M
| $861K | ﹤0.01% |
+9,364
| New | +$861K |
|
|
CNH
1533
CNH Industrial
CNH
$13.7B
| $860K | ﹤0.01% |
74,222
-67,400
| -48% | -$781K |
|
1534
Colony Bankcorp
CBAN
$304M
| $859K | ﹤0.01% |
56,934
+46,682
| +455% | +$704K |
|
1535
SpartanNash
SPTN
$896M
| $853K | ﹤0.01% |
+28,265
| New | +$853K |
|
1536
WesBanco
WSBC
$3.03B
| $852K | ﹤0.01% |
+26,879
| New | +$852K |
|
1537
Athira Pharma
ATHA
$14.3M
| $849K | ﹤0.01% |
278,433
+210,176
| +308% | +$641K |
|
1538
Kezar Life Sciences
KZR
$29.3M
| $849K | ﹤0.01% |
10,260
-42,317
| -80% | -$3.5M |
|
1539
New York Times
NYT
$9.57B
| $849K | ﹤0.01% |
+30,415
| New | +$849K |
|
1540
Peapack-Gladstone Financial
PGC
$516M
| $848K | ﹤0.01% |
28,562
+4,464
| +19% | +$133K |
|
|
BCOV
1541
DELISTED
Brightcove, Inc.
BCOV
| $846K | ﹤0.01% |
133,795
-34,025
| -20% | -$215K |
|
1542
M/I Homes
MHO
$4.06B
| $843K | ﹤0.01% |
21,259
-48,604
| -70% | -$1.93M |
|
1543
Root
ROOT
$1.53B
| $843K | ﹤0.01% |
39,375
-11,907
| -23% | -$255K |
|
|
AFMD
1544
DELISTED
Affimed
AFMD
| $840K | ﹤0.01% |
+30,321
| New | +$840K |
|
1545
Alamo Group
ALG
$2.49B
| $838K | ﹤0.01% |
7,196
+1,073
| +18% | +$125K |
|
1546
Daktronics
DAKT
$1.15B
| $836K | ﹤0.01% |
277,629
+36,775
| +15% | +$111K |
|
1547
Northeast Bank
NBN
$941M
| $831K | ﹤0.01% |
22,753
-579
| -2% | -$21.1K |
|
1548
Acadia Pharmaceuticals
ACAD
$3.96B
| $828K | ﹤0.01% |
58,800
-181,671
| -76% | -$2.56M |
|
1549
Laureate Education
LAUR
$4.33B
| $828K | ﹤0.01% |
71,600
-167,534
| -70% | -$1.94M |
|
1550
ARS Pharmaceuticals
SPRY
$995M
| $820K | ﹤0.01% |
193,500
-207,676
| -52% | -$880K |
|